clinical trial · NCT00944541
Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
French National Agency for Research on AIDS and Viral Hepatitis·phase2·completed·n = 60
HIV InfectionHIV Infectionsmaraviroc
brief summary
This pilot study aims to evaluate Maraviroc intensification strategy during 24 weeks in HIV infected patients under efficient (CV\< 50 cp/mL), controlled antiretroviral therapy (≥ 6 months) and uncompleted immune restoration (CD4\<350 cells/mL and CD4 earning \<100 cells/mL during last 24 months). The study will include 60 patients whose follow up is carried out for 48 weeks. recruitment period will be maintained for 12 months.
started
Sep 1, 2009
primary completion
Aug 1, 2010
completion
Jan 1, 2011
last updated
Apr 6, 2026
official title
Pilot Study Evaluating Maraviroc (Celsentri®)Intensification Benefit in HIV Infected Patients Presenting Insufficient Immune Restoration Despite Controlled Viral Load With Antiretroviral Treatment. ANRS 145 MARIMUNO
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol